More testing is only going to further confirm that Inoviq will become a market leader in its field. Not sure how you can take any negative from an announcement highlighting a company with a MC of less than 60m has a product that is outperforming overall by around 23% its competitors worth billions. Be interesting to see what effect on the sp attending a Cancer conference where there will be many academic and industry leaders present. Personally I am seeing this as an opportunity. Sp has been low mainly due to lack of volume. Once that returns it will head north quickly imo.
More testing is only going to further confirm that Inoviq will...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |